pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Diagnostics Company · news · pharmadog
← back to Diagnostics Company
News · Diagnostics Company
53
stories
1d
Opinion: AI has created a shadow medical system
stat
2d
Craif raises $33M to boost work on its urine test for cancer
fiercebiotech
3d
FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify
fiercebiotech
4d
How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and Medicine
biospace
9d
Austria’s new growth fund could further bolster its dynamic biotech innovation economy
biospace
10d
Opinion: We prepared for Ebola — but not this Ebola
stat
10d
Opinion: We prepared for Ebola — but not this Ebola
stat
10d
Labcorp nabs FDA green light for BRAF melanoma diagnostic
fiercebiotech
13d
FDA to hold adcomm for Grail cancer test that failed in large, randomized trial
endpoints
14d
Roche adds cyclospora PCR tests as outbreak widens
fiercebiotech
14d
Opinion: STAT+: Stop asking if AI is good for medicine
stat
15d
STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
stat
16d
KKR inks $5.7B deal to take medtech manufacturing giant Integer private
fiercebiotech
17d
Curium strikes up to $8B deal for radiopharma rival Lantheus
fiercebiotech
21d
Opinion: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases
stat
21d
Labcorp posts higher Q2 earnings on strength of diagnostics, lab services; adjusts full-year guidance
fiercebiotech
23d
Guardant Health taps Patrick Dempsey for emotional colorectal cancer awareness video
fiercebiotech
23d
Opinion: STAT+: Dementia finally has a business model
stat
24d
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
fiercebiotech
25d
Labcorp launches DTC ‘Genetic Health Panel’ to seek out multiple diseases
fiercebiotech
28d
STAT+: HHS to convene experts on standards for clinical AI
stat
28d
Roche's late stage pipeline 'so full,' CEO Schinecker not feeling pressure to add on
biospace
28d
Roche Diagnostics growth remains muted amid China headwinds
fiercebiotech
Jul 21, 26
Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial role
fiercebiotech
Jul 21, 26
Recon: Novo sues Lilly over weight-loss drug ads; Gilead, Merck say HIV pill keeps HIV suppressed in two Phase 3 trials
raps
Jul 20, 26
Tempus to acquire cancer test maker Personalis for $1.5B
biopharma dive
Jul 20, 26
Tempus to buy cancer test-maker Personalis for $1.5B
biopharma dive
Jul 20, 26
Tempus buys out cancer genomics partner Personalis in $1.5 billion deal
fiercebiotech
Jul 20, 26
BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’
fiercebiotech
Jul 19, 26
Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businesses
fiercebiotech
← prev
page 1 of 2
next →
